|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Unrestricted cash | |||
| Prepaid expenses | |||
| Total Current Assets | |||
| TOTAL ASSETS | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT) | |||
| Current Liabilities | |||
| Accounts payable | |||
| Bonds issued and outstanding at par | |||
| Advances from related party | |||
| Total Current Liabilities | |||
| Bonds issued and oustanding at par | |||
| Bonds issued and outstanding at par | |||
| Total Liabilities | |||
| Common stock, $0.01 per share par value, 3,000 shares authorized, issued and outstanding at March 31, 2026 and December 31, 2025 | |||
| Retained earnings | |||
| Total Equity | |||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT) |
Loading...